Synergistic Protection of Combined Probiotic Conditioned Media against Neonatal Necrotizing Enterocolitis-Like Intestinal Injury

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Shiou, Sheng Ru ^a   Yu, Yueyue ^a   Guo, Yuee ^a   He, Shu Mei ^b   Mziray Andrew, C Haikaeli ^c   Hoenig, Jeanette ^d   Sun, Jun ^e   Petrof, Elaine O ^b   Claud, Erika C ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b QUEEN S UNIVERSITY   (Canada)

^c SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Edward Hospital   (United States)

^e RUSH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PROBIOTIC AGENT; PROTEASOME; PROTEIN ZO1; TUMOR NECROSIS FACTOR ALPHA; CULTURE MEDIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIFIDOBACTERIUM LONGUM INFANTIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DOWN REGULATION; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GENE LOCATION; INJURY SEVERITY; INTESTINE INJURY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS PLANTARUM; LIVER PARENCHYMA; NECROTIZING ENTEROCOLITIS; NEWBORN; NONHUMAN; PROPHYLAXIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; TIGHT JUNCTION; ZO1 GENE; ANIMAL; BIOSYNTHESIS; CULTURE MEDIUM; DRUG EFFECTS; ENTEROCOLITIS, NECROTIZING; FEMALE; INTESTINE; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHARMACOLOGY; PREGNANCY;

ANIMALS; ANIMALS, NEWBORN; CULTURE MEDIA, CONDITIONED; ENTEROCOLITIS, NECROTIZING; FEMALE; INTESTINES; NF-KAPPA B; PREGNANCY; PROBIOTICS; PROTEASOME ENDOPEPTIDASE COMPLEX; RATS; TIGHT JUNCTIONS; TUMOR NECROSIS FACTOR-ALPHA; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84878129314     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065108     Document Type: Article

References (80)

1. Holman RC, Stehr-Green JK, Zelasky MT, (1989) Necrotizing enterocolitis mortality in the United States, 1979-85. Am J Public Health 79: 987-989.
2. MacKendrick W, Caplan M, (1993) Necrotizing enterocolitis. New thoughts about pathogenesis and potential treatments. Pediatr Clin North Am 40: 1047-1059.
3. Thyoka M, de Coppi P, Eaton S, Khoo K, Hall NJ, et al. (2012) Advanced necrotizing enterocolitis part 1: mortality. Eur J Pediatr Surg 22: 8-12.
4. Fitzgibbons SC, Ching Y, Yu D, Carpenter J, Kenny M, et al. (2009) Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg 44: 1072-1075; discussion 1075-1076.
5. Piena-Spoel M, Albers MJ, ten Kate J, Tibboel D, (2001) Intestinal permeability in newborns with necrotizing enterocolitis and controls: Does the sugar absorption test provide guidelines for the time to (re-)introduce enteral nutrition? J Pediatr Surg 36: 587-592.
6. Caplan MS, MacKendrick W, (1993) Necrotizing enterocolitis: a review of pathogenetic mechanisms and implications for prevention. Pediatr Pathol 13: 357-369.
7. Claud EC, Walker WA, (2001) Hypothesis: inappropriate colonization of the premature intestine can cause neonatal necrotizing enterocolitis. Faseb J 15: 1398-1403.
8. Anand RJ, Leaphart CL, Mollen KP, Hackam DJ, (2007) The role of the intestinal barrier in the pathogenesis of necrotizing enterocolitis. Shock 27: 124-133.
9. Chung DH, Ethridge RT, Kim S, Owens-Stovall S, Hernandez A, et al. (2001) Molecular mechanisms contributing to necrotizing enterocolitis. Ann Surg 233: 835-842.
10. Claud EC, Walker WA, (2008) Bacterial colonization, probiotics, and necrotizing enterocolitis. J Clin Gastroenterol 42Suppl 2: S46-52.
11. Gionchetti P, Rizzello F, Venturi A, Campieri M, (2000) Probiotics in infective diarrhoea and inflammatory bowel diseases. J Gastroenterol Hepatol 15: 489-493.
12. Niedzielin K, Kordecki H, Birkenfeld B, (2001) A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 13: 1143-1147.
13. Gionchetti P, Rizzello F, Venturi A, Brigidi P, Matteuzzi D, et al. (2000) Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology 119: 305-309.
14. Gareau MG, Sherman PM, Walker WA, (2010) Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol 7: 503-514.
15. Kleessen B, Bunke H, Tovar K, Noack J, Sawatzki G, (1995) Influence of two infant formulas and human milk on the development of the faecal flora in newborn infants. Acta Paediatr 84: 1347-1356.
16. Gewolb IH, Schwalbe RS, Taciak VL, Harrison TS, Panigrahi P, (1999) Stool microflora in extremely low birthweight infants. Arch Dis Child Fetal Neonatal Ed 80: F167-173.
17. Fanaro S, Chierici R, Guerrini P, Vigi V (2003) Intestinal microflora in early infancy: composition and development. Acta Paediatr Suppl 91: 48-55.
18. Caplan MS, Miller-Catchpole R, Kaup S, Russell T, Lickerman M, et al. (1999) Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Gastroenterology 117: 577-583.
19. Khailova L, Mount Patrick SK, Arganbright KM, Halpern MD, Kinouchi T, et al. (2009) Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 299: G1118-1127.
20. Khailova L, Dvorak K, Arganbright KM, Halpern MD, Kinouchi T, et al. (2009) Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 297: G940-949.
21. Lin PW, Nasr TR, Berardinelli AJ, Kumar A, Neish AS, (2008) The probiotic Lactobacillus GG may augment intestinal host defense by regulating apoptosis and promoting cytoprotective responses in the developing murine gut. Pediatr Res 64: 511-516.
22. Hunter CJ, Williams M, Petrosyan M, Guner Y, Mittal R, et al. (2009) Lactobacillus bulgaricus prevents intestinal epithelial cell injury caused by Enterobacter sakazakii-induced nitric oxide both in vitro and in the newborn rat model of necrotizing enterocolitis. Infect Immun 77: 1031-1043.
23. Liu Y, Fatheree NY, Mangalat N, Rhoads JM, (2012) Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-kappaB signaling in the intestine. Am J Physiol Gastrointest Liver Physiol 302: G608-617.
24. Underwood MA, Kananurak A, Coursodon CF, Adkins-Reick CK, Chu H, et al. (2012) Bifidobacterium bifidum in a rat model of necrotizing enterocolitis: antimicrobial peptide and protein responses. Pediatr Res 71: 546-551.
25. Lin HC, Hsu CH, Chen HL, Chung MY, Hsu JF, et al. (2008) Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 122: 693-700.
26. Hoyos AB, (1999) Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 3: 197-202.
27. Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, et al. (2005) Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 115: 1-4.
28. Antony SJ, (2000) Lactobacillemia: an emerging cause of infection in both the immunocompromised and the immunocompetent host. J Natl Med Assoc 92: 83-86.
29. Schlegel L, Lemerle S, Geslin P, (1998) Lactobacillus species as opportunistic pathogens in immunocompromised patients. Eur J Clin Microbiol Infect Dis 17: 887-888.
30. Borriello SP, Hammes WP, Holzapfel W, Marteau P, Schrezenmeir J, et al. (2003) Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 36: 775-780.
31. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, et al. (2005) Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115: 178-181.
32. Petrof EO, Claud EC, Sun J, Abramova T, Guo Y, et al. (2009) Bacteria-free solution derived from Lactobacillus plantarum inhibits multiple NF-kappaB pathways and inhibits proteasome function. Inflamm Bowel Dis 15: 1537-1547.
33. Tao Y, Drabik KA, Waypa TS, Musch MW, Alverdy JC, et al. (2006) Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. Am J Physiol Cell Physiol 290: C1018-1030.
34. Montalto M, Maggiano N, Ricci R, Curigliano V, Santoro L, et al. (2004) Lactobacillus acidophilus protects tight junctions from aspirin damage in HT-29 cells. Digestion 69: 225-228.
35. Ewaschuk JB, Diaz H, Meddings L, Diederichs B, Dmytrash A, et al. (2008) Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol 295: G1025-1034.
36. Caplan MS, Hedlund E, Adler L, Hsueh W, (1994) Role of asphyxia and feeding in a neonatal rat model of necrotizing enterocolitis. Pediatr Pathol 14: 1017-1028.
37. Israel EJ (1994) Neonatal necrotizing enterocolitis, a disease of the immature intestinal mucosal barrier. Acta Paediatr Suppl 396: 27-32.
38. Shiou SR, Yu Y, Chen S, Ciancio MJ, Petrof EO, et al. (2011) Erythropoietin protects intestinal epithelial barrier function and lowers the incidence of experimental neonatal necrotizing enterocolitis. J Biol Chem 286: 12123-12132.
39. Jilling T, Simon D, Lu J, Meng FJ, Li D, et al. (2006) The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. J Immunol 177: 3273-3282.
40. Fujiya M, Musch MW, Nakagawa Y, Hu S, Alverdy J, et al. (2007) The Bacillus subtilis quorum-sensing molecule CSF contributes to intestinal homeostasis via OCTN2, a host cell membrane transporter. Cell Host Microbe 1: 299-308.
41. Kolodziej LE, Lodolce JP, Chang JE, Schneider JR, Grimm WA, et al. (2011) TNFAIP3 maintains intestinal barrier function and supports epithelial cell tight junctions. PLoS One 6: e26352.
42. Napolitano LM, Koruda MJ, Meyer AA, Baker CC, (1996) The impact of femur fracture with associated soft tissue injury on immune function and intestinal permeability. Shock 5: 202-207.
43. Homma H, Hoy E, Xu DZ, Lu Q, Feinman R, et al. (2005) The female intestine is more resistant than the male intestine to gut injury and inflammation when subjected to conditions associated with shock states. Am J Physiol Gastrointest Liver Physiol 288: G466-472.
44. Thiagarajah JR, Gourmelon P, Griffiths NM, Lebrun F, Naftalin RJ, et al. (2000) Radiation induced cytochrome c release causes loss of rat colonic fluid absorption by damage to crypts and pericryptal myofibroblasts. Gut 47: 675-684.
45. Zufferey C, Erhart D, Saurer L, Mueller C, (2009) Production of interferon-gamma by activated T-cell receptor-alphabeta CD8alphabeta intestinal intraepithelial lymphocytes is required and sufficient for disruption of the intestinal barrier integrity. Immunology 128: 351-359.
46. Naftalin RJ, Pedley KC, (1999) Regional crypt function in rat large intestine in relation to fluid absorption and growth of the pericryptal sheath. J Physiol 514 (Pt 1): 211-227.
47. Foulkes EC, Mort TL, Buncher CR, (1991) Intestinal cadmium permeability in mature and immature rats. Proc Soc Exp Biol Med 197: 477-481.
48. Mackinnon AC, Tretiakova M, Henderson L, Mehta RG, Yan BC, et al. (2011) Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease. J Clin Pathol 64: 16-24.
49. Shiou SR, Yu Y, Chen S, Ciancio MJ, Petrof EO, et al. (2011) Erythropoietin protects intestinal epithelial barrier function and lowers the incidence of experimental neonatal necrotizing enterocolitis. J Biol Chem 286: 12123-12132.
50. Scanlon TC, Gottlieb B, Durcan TM, Fon EA, Beitel LK, et al. (2009) Isolation of human proteasomes and putative proteasome-interacting proteins using a novel affinity chromatography method. Exp Cell Res 315: 176-189.
51. Mueller TD, Feigon J, (2003) Structural determinants for the binding of ubiquitin-like domains to the proteasome. Embo J 22: 4634-4645.
52. Besche HC, Haas W, Gygi SP, Goldberg AL, (2009) Isolation of mammalian 26S proteasomes and p97/VCP complexes using the ubiquitin-like domain from HHR23B reveals novel proteasome-associated proteins. Biochemistry 48: 2538-2549.
53. Meng L, Mohan R, Kwok BH, Elofsson M, Sin N, et al. (1999) Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity. Proc Natl Acad Sci U S A 96: 10403-10408.
54. De Plaen IG, Liu SX, Tian R, Neequaye I, May MJ, et al. (2007) Inhibition of nuclear factor-kappaB ameliorates bowel injury and prolongs survival in a neonatal rat model of necrotizing enterocolitis. Pediatr Res 61: 716-721.
55. Traenckner EB, Wilk S, Baeuerle PA, (1994) A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. Embo J. 13: 5433-5441.
56. Puleo F, Meirelles K, Navaratnarajah M, Fitzpatrick L, Shumate ML, et al. (2010) Skeletal muscle catabolism in trinitrobenzene sulfonic acid-induced murine colitis. Metabolism 59: 1680-1690.
57. Clark JA, Doelle SM, Halpern MD, Saunders TA, Holubec H, et al. (2006) Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment. Am J Physiol Gastrointest Liver Physiol 291: G938-949.
58. Clark JA, Lane RH, Maclennan NK, Holubec H, Dvorakova K, et al. (2005) Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 288: G755-762.
59. Bin-Nun A, Bromiker R, Wilschanski M, Kaplan M, Rudensky B, et al. (2005) Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 147: 192-196.
60. Alkalay I, Yaron A, Hatzubai A, Jung S, Avraham A, et al. (1995) In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappa B. Mol Cell Biol. 15: 1294-1301.
61. Liu Y, Fatheree NY, Mangalat N, Rhoads JM, (2012) Lactobacillus reuteri strains reduce incidence and severity of experimental necrotizing enterocolitis via modulation of TLR4 and NF-kappaB signaling in the intestine. Am J Physiol Gastrointest Liver Physiol 302: G608-617.
62. Liu Y, Zhu L, Fatheree NY, Liu X, Pacheco SE, et al. (2009) Changes in intestinal Toll-like receptors and cytokines precede histological injury in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 297: G442-450.
63. D′Souza A, Cai CL, Kumar D, Cai F, Fordjour L, et al. (2012) Cytokines and Toll-like receptor signaling pathways in the terminal ileum of hypoxic/hyperoxic neonatal rats: benefits of probiotics supplementation. Am J Transl Res 4: 187-197.
64. D′Souza A, Fordjour L, Ahmad A, Cai C, Kumar D, et al. (2010) Effects of probiotics, prebiotics, and synbiotics on messenger RNA expression of caveolin-1, NOS, and genes regulating oxidative stress in the terminal ileum of formula-fed neonatal rats. Pediatr Res 67: 526-531.
65. Caplan MS, Sun XM, Hseuh W, Hageman JR, (1990) Role of platelet activating factor and tumor necrosis factor-alpha in neonatal necrotizing enterocolitis. J Pediatr 116: 960-964.
66. Mazzon E, Cuzzocrea S, (2008) Role of TNF-alpha in ileum tight junction alteration in mouse model of restraint stress. Am J Physiol Gastrointest Liver Physiol 294: G1268-1280.
67. Noth R, Stuber E, Hasler R, Nikolaus S, Kuhbacher T, et al. (2012) Anti-TNF-alpha antibodies improve intestinal barrier function in Crohn's disease. J Crohns Colitis 6: 464-469.
68. Liu H, Wang P, Cao M, Li M, Wang F, (2012) Protective role of oligomycin against intestinal epithelial barrier dysfunction caused by IFN-gamma and TNF-alpha. Cell Physiol Biochem 29: 799-808.
69. Anderson JM, Balda MS, Fanning AS, (1993) The structure and regulation of tight junctions. Curr Opin Cell Biol 5: 772-778.
70. Stevenson BR, Siliciano JD, Mooseker MS, Goodenough DA, (1986) Identification of ZO-1: a high molecular weight polypeptide associated with the tight junction (zonula occludens) in a variety of epithelia. J Cell Biol 103: 755-766.
71. Schneeberger EE, Lynch RD, (2004) The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 286: C1213-1228.
72. Zamora R, Bryan NS, Boyle P, Wong C, Milsom AB, et al. (2005) Nitrosative stress in an animal model of necrotizing enterocolitis. Free Radic Biol Med 39: 1428-1437.
73. Zamora R, Grishin A, Wong C, Boyle P, Wang J, et al. (2005) High-mobility group box 1 protein is an inflammatory mediator in necrotizing enterocolitis: protective effect of the macrophage deactivator semapimod. Am J Physiol Gastrointest Liver Physiol 289: G643-652.
74. Yan F, Cao H, Cover TL, Whitehead R, Washington MK, et al. (2007) Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132: 562-575.
75. Yan F, Polk DB, (2012) Characterization of a probiotic-derived soluble protein which reveals a mechanism of preventive and treatment effects of probiotics on intestinal inflammatory diseases. Gut Microbes 3: 25-28.
76. Seth A, Yan F, Polk DB, Rao RK, (2008) Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism. Am J Physiol Gastrointest Liver Physiol 294: G1060-1069.
77. Gareau MG, Sherman PM, Walker WA, (2010) Probiotics and the gut microbiota in intestinal health and disease. Nat Rev Gastroenterol Hepatol 7: 503-514.
78. Katan MB, (2012) Why the European Food Safety Authority was right to reject health claims for probiotics. Benef Microbes 3: 85-89.
79. Drago L, Rodighiero V, Celeste T, Rovetto L, De Vecchi E, (2010) Microbiological evaluation of commercial probiotic products available in the USA in 2009. J Chemother 22: 373-377.
80. Apostolou E, Kirjavainen PV, Saxelin M, Rautelin H, Valtonen V, et al. (2001) Good adhesion properties of probiotics: a potential risk for bacteremia? FEMS Immunol Med Microbiol 31: 35-39.